If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.
Transfer of Submission
Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.
The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.
The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.
The Author then receives an editorial decision from the journal.
Selection of another Journal
The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.
Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.
Michael Sinz Bristol Myers Squibb Princeton, NJ USA
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.